High prevalence of hyperhomocysteinemia due to marginal deficiency of cobalamin or folate in chronic myeloproliferative disorders

American Journal of Hematology

Volumn 65, Issue 2, 2000, Pages 136-140

  Faurschou, M ^a   Nielsen, O J ^a   Jensen, M K ^a   Hasselbalch, H C ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Cobalamin; Folate; Homocysteine; Myeloproliferative disorders

Indexed keywords

COBALAMIN; FOLIC ACID;

AMINO ACID DEFICIENCY; ARTICLE; BLOOD SAMPLING; CELL PROLIFERATION; DIET SUPPLEMENTATION; ERYTHROCYTOSIS; HUMAN; HUMAN CELL; HYPERHOMOCYSTEINEMIA; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA VERA; PREVALENCE; PRIORITY JOURNAL; THROMBOCYTE COUNT; VENOUS BLOOD; VITAMIN DEFICIENCY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; FEMALE; FOLIC ACID DEFICIENCY; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDERS; POLYCYTHEMIA VERA; PREVALENCE; REGRESSION ANALYSIS; RISK FACTORS; THROMBOCYTHEMIA, HEMORRHAGIC; THROMBOSIS; VITAMIN B 12 DEFICIENCY; VITAMINS;

EID: 0033832645     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-8652(200010)65:2<136::AID-AJH8>3.0.CO;2-6     Document Type: Article

References (36)

1. Polycythemia vera. The natural history of 1213 patients followed for 20 years
2. Polycythemia vera. A clinical study of 141 patients
3. Clinical course of essential thrombocythemia in 147 patients
4. Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia
5. Relation of platelet abnormalities to thrombosis and hemorrhage in chronic myeloproliferative disorders
6. Bleeding and thrombosis in the myeloproliferative disorders
7. Idiopathic myelofibrosis: A clinical study of 80 patients
8. Prevalence of specific thrombotic accidents in patients with thrombocytosis
9. Microvascular disturbances, thrombosis and bleeding in thrombocythemia: Current concepts and perspectives
10. Reduction of antithrombin III, protein C and protein S levels and activated protein C resistance in polycythemia vera and essential thrombocythemia patients with thrombosis
11. Increased levels of the soluble adhesion molecule E-selectin in patients with chronic myeloproliferative disorders and thromboembolic complications
12. Acquired von Willebrand disease in patients with high platelet counts
13. Hyperhomocysteinemia: A risk factor for arterial and venous thrombotic disease
14. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine
15. Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells
16. Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor
17. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen
18. How to diagnose cobalamin deficiency
19. Relationship between plasma homocysteine, vitamin status and extracranial carotid-artery stenosis in the Framingham study population
20. Age and gender specific reference intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin supplementation
21. Serum methylmalonic acid in uraemia
22. Plasma homocysteine in renal failure
23. Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease, and drug therapy
24. Fasting plasma homocysteine as a sensitive parameter to antifolate effect. A study on psoriasis patients receiving low-dose methotrexate treatment
25. Plasma homocysteine in children with acute lymphoblastic leukemia: Changes during a chemotherapeutic regimen including methotrexate
26. Plasma homocysteine levels in 10 patients with polycythemia
27. Homocysteine levels in polycythemia vera and essential thrombocythaemia
28. Homocysteinemia due to folate deficiency
29. Folic acid: An innocuous means to reduce plasma homocysteine
30. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies
31. Diagnosis of cobalamin deficiency. I. usefulness of serum methylmalonic acid and total homocysteine concentrations
32. Solid-phase sample extraction for rapid determination of methylmalonic acid in serum and urine by a stable-isotope-dilution method
33. Homocysteine in plasma: Stabilization of blood samples with fluoride
34. Treatment of hyperhomocysteinemia: Physiological basis
35. Obligate genetic expression in tumor cells of fetal membrane property mediating 'folate' transport: Biological significance and implications for improved therapy of human cancer
36. 12 and folate deficiency and in leukemia